Why Is XRP Rallying 8% Today?

Ripple’s native token, XRP (CRYPTO: XRP), has experienced a surge of 8% today, surpassing the performance of Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:

Ripple’s native token, XRP (CRYPTO: ETH) in the last 24 hours.

What Happened: As of the time of writing, XRP was trading at $0.67, while both Bitcoin and Ethereum recorded slight declines of 1.06% and 0.73% respectively during the same period.

This surge coincides with Ripple’s collaboration with the National Bank of Georgia, as they join forces to explore the potential use cases of a central bank digital currency (CBDC) within the country.

In a statement, Ripple expressed their belief that by leveraging the Ripple CBDC Platform. “By harnessing the power of the Ripple CBDC Platform, this pilot will pave the way for transformative advancements in the utilization of Blockchain technology within the public and private sectors,” the statement said.

Will The SEC Finally Approve Long-Awaited Bitcoin Spot ETF? Ask industry experts directly at Benzinga’s Future of Digital Assets event happening in NYC on Nov. 14, 2023. Be a part of the discussions where you won’t just be a passive spectator. Don’t let this chance slip away – secure early bird discounted tickets now!

See More: A Stay At The Floating Palace From James Bond’s ‘Octopussy

Why It Matters: Additionally, recent rumors have circulated regarding Ripple’s potential foray into an Initial Public Offering (IPO). Naturally, concerns have surfaced within the XRP community regarding the potential long-term impact on the value of XRP if Ripple were to proceed with an IPO. 

However, it should be noted that Ripple has not made an official declaration regarding their intention to go public. 

Photo Courtesy: Diamond Visuals On Shutterstock.com

Read Next: Here’s How Much You Should Invest In Shiba Inu Today For A $1M Payday If SHIB Hits 1 Cent?

Total
0
Shares
Related Posts
Read More

Organigram Reports 16% YoY Revenue Drop But Kicks Off Year ‘With A Bang,’ Says CEO On Hundreds Of Millions In Tobacco Giant BAT Investment

Canadian cannabis producer Organigram reported a 16% decrease in net revenue for Q1 2024 due to a reduction in international revenue and medical sales. The company announced in November that it had received a CA$124.6m ($93m) strategic equity investment from BT DE Investments, a subsidiary of tobacco company British American Tobacco. Organigram shareholders approved the investment in January, and the company completed the first tranche of the investment for $41.5m. CEO Beena Goldenberg said the investment had removed a significant amount of risk from Organigram's business and enhanced its competitive advantages. The investment allows the cannabis producer to utilize its facilities, research and development capabilities, and market leadership to expand its reach within the Canadian market and beyond. Organigram's Q1 financial highlights included a drop in gross margin, an increase in selling and administrative expenses, a net loss of CA$15.8m, and positive adjusted EBITDA of CA$135,000.

BTI